<?xml version="1.0" encoding="UTF-8"?>
<p id="par0155">Convalescent plasma has usually been administered to severely/critically ill patients in the case series reported so far. However, it is not recommended to apply this treatment after the initiation of cytokine storm. In a guidance issued by FDA, CCP is recommended to be administering between 7â€“14 days in COVID-19 patients that comply with the specified criteria [
 <xref rid="bib0040" ref-type="bibr">8</xref>].
</p>
